Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol.
Saved in:
| Title: | Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol. |
|---|---|
| Authors: | Hentzien, Maxime1,2 (AUTHOR), Bonnet, Fabrice3,4 (AUTHOR), Bernasconi, Enos5 (AUTHOR), Biver, Emmanuel6 (AUTHOR), Braun, Dominique L.7 (AUTHOR), Munting, Aline8 (AUTHOR), Leuzinger, Karoline9 (AUTHOR), Leleux, Olivier4 (AUTHOR), Musardo, Stefano1 (AUTHOR), Prendki, Virginie10 (AUTHOR), Schmid, Patrick11 (AUTHOR), Staehelin, Cornelia12 (AUTHOR), Stoeckle, Marcel13 (AUTHOR), Walti, Carla S.13 (AUTHOR), Wittkop, Linda3,14,15 (AUTHOR), Appay, Victor16 (AUTHOR), Didierlaurent, Arnaud M.17 (AUTHOR) arnaud.didierlaurent@unige.ch, Calmy, Alexandra1 (AUTHOR) Alexandra.Calmy@hug.ch |
| Source: | BMC Infectious Diseases. 3/19/2024, Vol. 24 Issue 1, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
